Utility of Aprepitant in the Management of Pediatric Patients with Cyclical Vomiting Syndrome.

ABSTRACT: Introduction: Cyclical vomiting syndrome (CVS) is a recurrent debilitating illness characterized by intense episodes of nausea and emesis with widely varied pharmacological management across the country. Aprepitant is now increasingly used in patients with CVS. The impact of aprepitant as an abortive therapy in the readmission of pediatric patients with CVS is currently unknown. Methodology: We analyzed all pediatric patients with a primary diagnosis of CVS using the ICD-10 code in the Pediatric Health Information System database of the Children's Hospital Association. We evaluated the demographic data, comorbid conditions, and management details during the inpatient stay. CVS patients who received aprepitant during their inpatient hospitalization were compared with patients

SUBMITTER: Thavamani A 

PROVIDER: S-EPMC11677684 | biostudies-literature | 2024 Dec

REPOSITORIES: biostudies-literature